Aptose Biosciences financials at a glance

+ Portfolio

The revenue of Aptose Biosciences is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -10.29 Dollars per share in 2023, which was 33.19 higher than 2021. And about -0.06621 billion Dollars are reported as free cash flow in the financials of Aptose Biosciences 2023. No dividends were paid to the shareholders of the Aptose Biosciences stock TSX:APS in the financial year 2023.

C$0.00M

Revenue

C$-9.22

Earnings Per Share

0.00%

Gross Margin %

C$-44.48M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-9.22

Gross Margin %

0.00

Free Cash Flow

-44.48

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2006	2005	2004
Rev.	Revenue	N/A	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.03M	C$0.01M	C$0.80M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	C$-7.78	C$-9.22	C$-13.80	C$-12.62	C$-10.75	C$-14.25	C$-10.03	C$-21.90	C$-18.45	C$-10.05	C$-,540.05	C$-,702.07	C$-1,285.00
Div.	Dividends	N/A	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	6.2M	6.15M	5.93M	5.08M	2.77M	1.83M	1.05M	0.8M	0.78M	0.03M	0.03M	0.03M
OCF	Operating Cash Flow	N/A	C$-44.45M	C$-54.58M	C$-42.54M	C$-29.70M	C$-31.05M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M
FCF	Free Cash Flow	N/A	C$-44.48M	C$-54.85M	C$-42.64M	C$-29.84M	C$-31.49M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M	C$0.00M
FCFS	Free Cash Flow Per Share	C$-6.95	C$-5.26	C$-0.49	C$-0.42	C$-0.43	C$-0.70	C$-0.46	C$-0.97	C$-0.85	C$-1.02	C$0.00	C$0.00	C$0.00

Aptose Biosciences financials at a glance

Financials

Discover